Bhanot O S, Khan S A, Chambers R W
J Biol Chem. 1979 Dec 25;254(24):12684-93.
A new system for studying the molecular mechanisms of mutation by carcinogens is described. The system involves (a) site-specific modification of the essential gene G in phi X174 replicative form DNA by a combination of chemical and enzymatic steps; (b) production of mutant virus carrying a change at a single preselected site by transfection of spheroplasts with the site modified phi X174 DNA; (c) detection and propagation of mutants using a host carrying the plasmid, p phi XG, that rescues all type of gene G mutants by complementation; (d) identification of the mutation in the progeny virus by isolating and sequencing mutant phi X174 DNA in the region that carried the parental, site-specific change. To demonstrate that this system is operational, we have produced a previously unknown phi X174 gene G mutant carrying a C leads to T base change at position 2401 of the viral (plus) strand. This preplanned, nonsense (amber) mutant was obtained by changing G to A at the appropriate position in a chemically synthesized, octadeoxynucleotide, minus strand primer; elongating this enzymatically with Escherichia coli DNA polymerase I (larger fragment) (lacking 5' leads to 3' exonuclease activity) to a 17-mer; and repriming to obtain the site-modified phi X174 replicative form DNA enzymatically with E. coli DNA polymerase I (large fragment) and T4 DNA ligase. After transfection of spheroplasts with the heteroduplex DNA, the lysate was screened for mutant virus with permissive (carrying p phi XG) and nonpermissive (without p phi XG) host cells. About 1% of the progeny virus were mutants. Out of 15 isolates, 11 were suppressible by an amber Su1+ (serine) or an ochre Su8+ (glutamine) suppressor. The other 4 isolates were not suppressed at all. Replicative form DNA produced from one of the suppressible mutants was shown (by sequencing) to contain the expected C leads to T change at the preselected site in the viral strand. Replicative form DNA from one of the nonsuppressible mutants was partially sequenced. No change was found at or around position 2401. The nature of the mutation(s) in these isolates is still unknown. The occurrence of mutations outside the preselected sites represent a potential problem for our projected studies, but additional data is required before the problem can be fully evaluated. In spite of this, it should be possible to study, in vivo, the biological effects of any site-specific modification (including covalent modifications by carcinogens) that can be introduced into gene G of phi X174 DNA via a synthetic, oligonucleotide primer.
本文描述了一种用于研究致癌物致突变分子机制的新系统。该系统包括:(a) 通过化学和酶促步骤相结合,对φX174复制型DNA中的必需基因G进行位点特异性修饰;(b) 用位点修饰的φX174 DNA转染原生质球,产生在单个预选位点发生改变的突变病毒;(c) 使用携带质粒pφXG的宿主检测和繁殖突变体,该质粒通过互补作用拯救所有类型的基因G突变体;(d) 通过分离和测序携带亲本位点特异性改变区域的突变φX174 DNA,鉴定子代病毒中的突变。为证明该系统可行,我们产生了一种先前未知的φX174基因G突变体,其病毒(正)链第2401位的C突变为T。通过在化学合成的十八脱氧核苷酸负链引物的适当位置将G变为A获得这种预先设计的无义(琥珀)突变体;用大肠杆菌DNA聚合酶I(大片段)(缺乏5'→3'核酸外切酶活性)将其酶促延伸为17聚体;并用大肠杆菌DNA聚合酶I(大片段)和T4 DNA连接酶酶促重新引物,以获得位点修饰的φXl74复制型DNA。用异源双链DNA转染原生质球后,用允许(携带pφXG)和非允许(不携带pφXG)宿主细胞筛选裂解物中的突变病毒。约1%的子代病毒是突变体。在15个分离株中,11个可被琥珀型Su1 +(丝氨酸)或赭石型Su8 +(谷氨酰胺)抑制子抑制。另外4个分离株完全不被抑制。对其中一个可抑制突变体产生的复制型DNA进行测序,结果显示病毒链预选位点处含有预期的C→T改变。对其中一个不可抑制突变体的复制型DNA进行了部分测序。在2401位及其周围未发现变化。这些分离株中突变的性质仍然未知。预选位点之外的突变的出现对我们预计的研究来说是一个潜在问题,但在能够全面评估该问题之前还需要更多数据。尽管如此,应该有可能在体内研究通过合成寡核苷酸引物引入到φX174 DNA基因G中的任何位点特异性修饰(包括致癌物引起的共价修饰)的生物学效应。